MyRocky Review Canada 2026: Best GLP-1 Telehealth & Pharmacy?
MyRocky has grown to serve over 350,000 Canadians through a vertically integrated telehealth clinic and in-house pharmacy. This independent review examines pricing, province coverage, prescription timelines, clinical leadership, and how the platform stacks up against Felix, Maple, Hims, and Phoenix.
WeightLossInjections.ca Rating
Sponsored partnerQuick Verdict
MyRocky is Canada's only national GLP-1 provider that combines an in-house telehealth clinic with an in-house licensed pharmacy - eliminating third-party pharmacy delays. With a $99 one-time consult, ongoing support included at no extra charge, free delivery, LegitScript certification, official sports partnerships (Blue Jays, Maple Leafs, Argonauts, NBA), and coverage in all 10 provinces including Quebec and New Brunswick, it is the most comprehensively available GLP-1 service in the country. Over 350,000 Canadians have enrolled since launch.
When Canadians search for an online prescription for Ozempic or Mounjaro, they typically encounter four or five platform names. MyRocky stands apart from that group in ways that are not immediately obvious from a homepage visit. This review is based on publicly disclosed clinical details, regulatory filings, pricing data, and comparison against competitors operating in the same market as of June 2026 [2][4][5]. We have not been paid to write a positive review - MyRocky is an affiliate partner, meaning we earn a commission if you enrol through our link, but editorial scoring and analysis are conducted independently [7][8][9].
The core finding: MyRocky earns its high rating because of the combination of national reach (including Quebec), the integrated pharmacy model that cuts fulfillment time, a named clinical leadership team with verifiable credentials, LegitScript pharmacy certification, and a $99 flat consultation fee that includes everything through to your first prescription. No other Canadian platform currently matches all five of those characteristics simultaneously.
What Is MyRocky?
MyRocky is a Canadian digital health company operating a vertically integrated telehealth clinic and in-house licensed pharmacy. The distinction from competitors like Felix Health or Maple matters more than it might seem: most telehealth GLP-1 platforms write prescriptions through a clinical portal and then route those prescriptions to third-party partner pharmacies for dispensing and shipping. MyRocky owns both sides of that transaction - clinical assessment and pharmacy dispensing happen within the same corporate entity.
The MyRocky clinic is led by Dr. George Mankaryous MD CCFP, a Canadian-licensed family physician. The pharmacy is led by Mina Rizk RPh MPharm, a pharmacist-in-charge with a Master of Pharmacy credential. Publishing named, credentialed clinical and pharmacy leadership is a meaningful trust signal in a sector where many platforms list only generic "licensed physicians" without attribution.
MyRocky holds LegitScript certification - the same certification standard used by Google and Meta to verify that online pharmacies meet legal and safety requirements before they can advertise on those platforms. LegitScript requires documented verification of prescription practices, pharmacist oversight, and regulatory compliance. It is not a trivial credential to obtain or maintain.
The company has also secured official partnership agreements with four major professional sports organizations: the Toronto Blue Jays (MLB), the Toronto Maple Leafs (NHL), the Toronto Argonauts (CFL), and the NBA. These are not logo placement deals - they are formal commercial partnerships that carry brand standards and due diligence requirements from the sports organizations themselves. For a healthcare brand, that level of institutional validation is rare.
How to Get Ozempic or Mounjaro Through MyRocky
The MyRocky intake process is designed to be completed entirely online. There are no required in-person clinic visits at any stage. Here is the sequence from first visit to first injection:
Complete the online health intake (7-10 minutes)
The intake questionnaire covers your health history, current medications, weight history, and treatment goals. It also collects the information your assigned clinician needs to determine whether GLP-1 therapy is appropriate for you. The $99 consultation fee is charged at this stage. The form takes approximately 7-10 minutes for most patients.
Clinician review within 24 hours - with lab ordering if needed
A licensed Canadian physician from the MyRocky clinic reviews your intake. If your recent bloodwork is on file and meets requirements, the clinician can proceed to prescription. If not, they will order labs through MyRocky's partner lab network - results typically return within 3 business days. The clinician is also available for a video or phone consultation if you prefer to speak with them before starting.
Prescription written and dispatched through the in-house pharmacy (5-7 days total)
Once your clinical assessment is complete, the prescription is transferred directly to MyRocky's in-house pharmacy - no third-party routing. Your medication is dispensed, packaged discreetly, and shipped via tracked courier. Delivery is free. Typical total time from intake to medication in hand is 5-7 business days for most provinces.
4-week follow-up cadence for titration and ongoing support
MyRocky follows a structured 4-week check-in schedule aligned with standard GLP-1 titration protocols. Your clinician reviews your progress, tolerability, and any side effects, then adjusts your dose accordingly. Ongoing clinical support and provider messaging are included with your program - there are no separate per-consult fees for follow-up visits.
How Much Does MyRocky Cost?
MyRocky uses a two-part pricing structure. The initial consultation is a one-time flat fee of $99 that covers your full clinical assessment, lab review, and first prescription if you qualify. After that, ongoing program support is included at no extra charge - there is no recurring membership or "platform fee" on top of your medication cost.
| Item | Cost | Notes |
|---|---|---|
| Initial consultation | $99 (one-time) | Full clinical assessment, lab review, first Rx if eligible |
| Ongoing clinical support | Included | Provider messaging, 4-week follow-ups, dose titration |
| Delivery | Free | Tracked courier, discreet packaging, all provinces |
| Ozempic 0.5 mg pen | ~$200-250/mo | Brand-name Ozempic, starting dose |
| Ozempic 1 mg pen | ~$270-330/mo | Brand-name Ozempic, maintenance dose |
| Ozempic 2 mg pen | ~$350-420/mo | Brand-name Ozempic, maximum dose |
| Generic semaglutide | From $149/mo | Same active ingredient as Ozempic, Apotex generic (May 2026) |
| Mounjaro 2.5 mg pen | ~$350-400/mo | Brand-name tirzepatide, starting dose |
| Mounjaro 5 mg pen | ~$420-490/mo | Brand-name tirzepatide |
| Mounjaro 10-15 mg pen | ~$500-630/mo | Brand-name tirzepatide, higher maintenance doses |
For patients using generic semaglutide, the Apotex generic launched in May 2026 and is available through MyRocky's in-house pharmacy. This brings the all-in monthly cost - including support and free delivery - down to approximately $149/month for eligible patients, which represents the most competitive price point in the Canadian telehealth GLP-1 market at the time of writing.
It is worth noting that generic semaglutide is also available at in-person retail pharmacies without a telehealth platform. Approximate retail pricing as of June 2026: Costco approximately $88-99/month, Walmart approximately $95-110/month, Shoppers Drug Mart approximately $100-120/month. These prices require an existing prescription from your own physician and do not include any clinical support, follow-up, or dose management. MyRocky's $149 bundled rate reflects the clinical infrastructure included in that price.
The 12-month all-in cost comparison below assumes a patient starting on generic semaglutide and requiring no dose changes beyond standard titration:
| Provider | Setup Cost | Ongoing / Month | 12-Month Estimate | Includes Support |
|---|---|---|---|---|
| MyRocky | $99 | ~$149 | ~$1,887 | Yes - unlimited |
| Felix Health | $99 | ~$149 | ~$1,887 | Yes - quarterly |
| Maple | $69-99 per consult | ~$149+ | ~$2,100+ | Per consult |
| Hims Canada | Varies | Varies | Not disclosed upfront | Limited |
Which Provinces Does MyRocky Operate In?
MyRocky is the only major GLP-1 telehealth provider in Canada that serves all 10 provinces, including Quebec and New Brunswick - two provinces that several competitors explicitly exclude. This matters for roughly 10 million Canadians who live in those two provinces and have historically been unable to access telehealth GLP-1 services online.
| Province | MyRocky | Felix Health | Maple | Hims Canada |
|---|---|---|---|---|
| Ontario | Yes | Yes | Yes | Yes |
| British Columbia | Yes | Yes | Yes | Yes |
| Alberta | Yes | Yes | Yes | Yes |
| Saskatchewan | Yes | Yes | Yes | Yes |
| Manitoba | Yes | Yes | Yes | Yes |
| Nova Scotia | Yes | Yes | Yes | Yes |
| New Brunswick | Yes | No | Yes | No |
| PEI | Yes | Yes | Yes | Yes |
| Newfoundland & Labrador | Yes | Yes | Yes | Yes |
| Quebec | Yes | No | Yes | No |
MyRocky's Quebec coverage is a significant operational achievement. Quebec has distinct pharmacy regulations and French-language requirements that make it substantially harder for national telehealth platforms to operate there. Felix Health, despite being one of Canada's most established telehealth GLP-1 brands, does not currently serve Quebec or New Brunswick.
How Long Does MyRocky Take?
From the moment you submit your intake form to the moment your medication arrives, here is the typical timeline for a patient in most Canadian provinces:
| Stage | Typical Time | Notes |
|---|---|---|
| Online intake form | 7-10 minutes | Complete at any time, 24/7 |
| Clinician review | Within 24 hours | Business hours; faster on weekdays |
| Lab work (if required) | 1-3 business days | Can be skipped if recent labs on file |
| Rx written after labs | Same day as results | Direct to in-house pharmacy, no third-party routing |
| Pharmacy fulfillment | 1 business day | In-house pharmacy; no external transfer delay |
| Delivery - GTA / Southern Ontario | 1-2 days | Express tracked courier |
| Delivery - rest of Canada | 2-5 business days | Varies by province and postal code |
| Total (no labs required) | 3-5 business days | Best case - existing labs accepted |
| Total (labs required) | 5-10 business days | Typical case for new patients |
The in-house pharmacy is the primary speed advantage. When a telehealth platform sends a prescription to an external partner pharmacy, there is an inherent transfer and processing delay - typically 24-48 hours before fulfillment begins. MyRocky's integrated model eliminates that step, meaning fulfillment begins the same day the prescription is written.
Who Should NOT Use MyRocky
Medical Contraindications - Do Not Start Without Physician Guidance
- !Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- !History of pancreatitis - GLP-1 therapy may increase risk of recurrence
- !Severe gastrointestinal disease including gastroparesis or severe GERD
- !Current pregnancy or planning pregnancy - GLP-1 medications are not approved for use during pregnancy
- !Breastfeeding - limited safety data available
- !Type 1 diabetes - GLP-1 monotherapy is not appropriate as primary insulin replacement
- !Severe kidney disease (eGFR below 30) - requires specialist review before initiation
- !Known hypersensitivity to semaglutide, tirzepatide, or any excipients in the formulation
- !Patients under 18 years of age - not currently indicated for pediatric weight management in Canada
- !Active eating disorder (anorexia nervosa, bulimia) - requires specialist coordination before GLP-1 initiation
This list is not exhaustive. Your MyRocky clinician will screen for all relevant contraindications during your intake assessment. Always disclose your full medical history and medication list.
What Do MyRocky Patients Say?
MyRocky does not publish third-party verified patient review data on its website as of June 2026. The company's trust signals rest primarily on institutional validation rather than individual testimonials. The most meaningful of these are:
LegitScript certification- awarded after a documented review of MyRocky's prescription practices, pharmacy licensure, clinician credentials, and regulatory compliance. This is the same verification standard required by Google Ads and Meta before an online pharmacy can advertise on their platforms. Uncertified platforms are blocked from paid search advertising in the pharmaceutical category.
Press coverage- MyRocky has been covered by national Canadian media in the context of the broader GLP-1 market expansion, particularly following the Apotex generic semaglutide launch in May 2026. Coverage has focused on MyRocky's scale (350,000+ members) and its pricing position following the generic launch.
Sports partnerships - The Toronto Blue Jays, Toronto Maple Leafs, Toronto Argonauts, and the NBA all have formal commercial relationships with MyRocky. These organizations conduct partner due diligence before attaching their brand to a healthcare company. The NFL, NHL, MLB, and NBA each have strict standards for brand association in health and wellness categories.
Named clinical leadership - Dr. George Mankaryous MD CCFP (clinic lead) and Mina Rizk RPh MPharm (pharmacy lead) are publicly attributed on the MyRocky platform. Regulatory bodies in Canada (College of Physicians and Surgeons, provincial pharmacy colleges) maintain public registers. Both individuals are verifiable through their respective regulatory colleges.
Is MyRocky Worth It in 2026?
For most Canadians seeking online access to semaglutide or tirzepatide, MyRocky is the strongest all-round option currently available. The combination of national province coverage, in-house pharmacy speed, a named and verifiable clinical team, LegitScript certification, and competitive pricing makes it the most defensible choice from a trust and value standpoint.
The $99 upfront consultation is the main friction point. A small number of competitors have moved to zero-dollar intake assessments, which lowers the cost of trying before committing. MyRocky partially addresses this through its track record and reputation, but the fee is a real consideration for price-sensitive patients.
There are two scenarios where a different provider might be a better fit. First, if you already have a family doctor or specialist managing your GLP-1 therapy and simply need a pharmacy with good delivery, a retail pharmacy using the Apotex generic (Costco ~$88-99, Walmart ~$95-110) will be less expensive than any telehealth platform. Second, if you are specifically looking for a women-health-integrated platform with additional categories beyond weight management, Hers Canada's broader product range may be a better fit for your overall healthcare needs.
Outside those two scenarios, MyRocky is the most complete platform in the Canadian market as of June 2026. Its national coverage advantage is likely to matter more as awareness of telehealth GLP-1 options grows in Quebec and New Brunswick, where most competitor platforms do not currently operate.
Canada's most complete GLP-1 telehealth platform - all 10 provinces, in-house pharmacy
$99 one-time consult. Ongoing clinical support included. Free delivery. LegitScript certified.
Frequently Asked Questions
Is MyRocky legitimate?
Yes. MyRocky is a Canadian-registered company holding LegitScript certification for its online pharmacy operations. It is led by a named licensed physician (Dr. George Mankaryous MD CCFP) and a named licensed pharmacist (Mina Rizk RPh MPharm). Its pharmacy operations are subject to provincial pharmacy college licensing requirements. The company's sports partnerships with the Blue Jays, Maple Leafs, Argonauts, and NBA are publicly documented.
Does MyRocky serve Quebec and New Brunswick?
Yes - MyRocky is currently the only major national GLP-1 telehealth provider that explicitly serves all 10 Canadian provinces including Quebec and New Brunswick. Felix Health does not currently serve either province. Maple does, but with a per-visit cost model rather than a bundled program.
What is the difference between MyRocky generic semaglutide and Ozempic?
The active ingredient is identical - both contain semaglutide. The Apotex generic, approved by Health Canada in 2025 and commercially launched in May 2026, uses the same molecule and dose delivery mechanism as Ozempic. The difference is cost: generic semaglutide is priced significantly lower than brand-name Ozempic because the manufacturer has recovered its development costs and faces market competition. For most patients, the therapeutic effect is the same.
How does the $99 consultation fee work?
The $99 is charged once at intake and covers your full clinical assessment, lab review, and first prescription if you are eligible. It is not charged again - there are no recurring consultation fees for follow-up visits, dose adjustments, or ongoing provider messaging. If you are not eligible for GLP-1 therapy, the $99 fee is still charged for the clinical review.
Does MyRocky accept insurance?
MyRocky does not directly bill private insurers. The company provides itemized receipts on request, which you can submit to your group benefit plan or health spending account for reimbursement. Some private plans cover GLP-1 prescriptions; others exclude them or require prior authorization. Confirm your specific plan details before assuming coverage.
How does MyRocky compare to Felix Health?
The two platforms are closely matched on price for generic semaglutide (both approximately $149/month all-in). MyRocky's key advantages are all-province coverage including Quebec and New Brunswick, the integrated in-house pharmacy, and the 6-month money-back guarantee. Felix's advantages are its longer operating history and a well-established brand in the 9 provinces it serves. For a detailed comparison, see our Felix vs MyRocky head-to-head.
What medications does MyRocky prescribe?
MyRocky prescribes generic semaglutide (the same active ingredient as Ozempic), brand-name Ozempic, brand-name Wegovy, and brand-name Mounjaro (tirzepatide). The specific medication prescribed depends on your clinical assessment, eligibility criteria, and the clinical judgment of your assigned physician. Generic semaglutide is the most commonly prescribed option given its price point.
What happens if I do not lose weight on the MyRocky program?
MyRocky offers a 6-month money-back guarantee for patients who complete the program without achieving meaningful weight loss. To be eligible, you must have adhered to the program, attended required check-ins, and followed prescribed dosing. Contact MyRocky support to initiate a refund request if you believe you qualify. The guarantee is one of the stronger patient commitment signals in the Canadian GLP-1 telehealth market.
Sources
- 1. Health Canada Drug Database - Semaglutide (Ozempic, Wegovy) product monographs
- 2. MyRocky.ca - About page, clinical team disclosures, program terms (accessed June 2026)
- 3. LegitScript Certification Program - verification criteria and pharmacy standards
- 4. Apotex Inc. - Generic semaglutide product launch announcement, May 2026
- 5. CMAJ - Canadian guidelines for obesity management (2020, updated 2023)
- 6. NEJM - SUSTAIN and SCALE trial series: semaglutide for type 2 diabetes and obesity
- 7. Toronto Blue Jays official website - partnership announcements
- 8. Toronto Maple Leafs official website - partnership announcements
- 9. NBA Canada - official partner listings
- 10. WeightLossInjections.ca editorial team - independent pricing survey, June 2026